| ²é¿´: 1859 | »Ø¸´: 4 | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
smallbird119ľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÖú HEMA¼°PEGDMAµÄÉúÎïÏàÈÝÐÔÔõôÑù£¿
|
|||
|
ÎÒÓÃHEMA¼°PEGDMA½øÐн»Áª ±¾À´ÏëÖÆ±¸Ë®Äý½ºµÄ ÓõÄAPS¼°BIS×öÒý·¢¼Á¼°½»Áª¼Á ½á¹û37¶È¼ÓÈÈ24Сʱºó û³ÉÄý½º ±£³Ö³ÎÇå͸Ã÷µÄdz»ÆÉ«ÒºÌå pHÖµÔÚ4-5Ö®¼ä ÏëÎÊÎÊHEMA¼°PEGDMAÕâÁ½ÖÖ²ÄÁϵÄÉúÎïÏàÈÝÐÔÈçºÎÄØ£¿²»Ê¤¸Ð¼¤ [ À´×Ô¿ÆÑмÒ×å ΢ÇòÄÉÃ×Çò ] |
» ²ÂÄãϲ»¶
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©×ö¹ý·Ö×ÓʵÑé
ÒѾÓÐ10È˻ظ´
08¿ªÍ·
ÒѾÓÐ0È˻ظ´
ÉúÎïÎïÀí¡¢ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ66È˻ظ´
ÖпÆÖÐɽҩÎï´´ÐÂÑо¿Ôº£¨Ò©´´Ôº£©ÔõôÑù£¿
ÒѾÓÐ0È˻ظ´
ÉúÎïѧ308Çóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ6È˻ظ´
ÉúÎïѧ308Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©½ÓÊÜ¿çרҵ
ÒѾÓÐ11È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á½ÓÊÜ¿çרҵ
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
ºìÖÛÁ÷ÐÇ
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
Ö¾ÔÚ³ÉΪǧԪ»§£¡
- BM-EPI: 4
- Ó¦Öú: 304 (´óѧÉú)
- ¹ó±ö: 24.278
- ½ð±Ò: 2630
- É¢½ð: 55784
- ºì»¨: 208
- ɳ·¢: 719
- Ìû×Ó: 19854
- ÔÚÏß: 2621Сʱ
- ³æºÅ: 1304427
- ×¢²á: 2011-05-24
- ÐÔ±ð: GG
- רҵ: ·ÂÉú²ÄÁÏ
- ¹ÜϽ: ²ÄÁÏ×ÛºÏ

3Â¥2012-11-02 08:42:13
aircraftvip
ר¼Ò¹ËÎÊ (ÕýʽдÊÖ)
-

ר¼Ò¾Ñé: +40 - BM-EPI: 10
- Ó¦Öú: 232 (´óѧÉú)
- ¹ó±ö: 0.06
- ½ð±Ò: 7345.7
- É¢½ð: 24
- ºì»¨: 28
- Ìû×Ó: 987
- ÔÚÏß: 487.4Сʱ
- ³æºÅ: 1007878
- ×¢²á: 2010-04-28
- ÐÔ±ð: GG
- רҵ: ¸ß·Ö×Ӻϳɻ¯Ñ§
- ¹ÜϽ: ÉúÎï²ÄÁÏ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ºìÖÛÁ÷ÐÇ: ½ð±Ò+1, ר¼Ò¿¼ºË, »¶ÓÀ´µ½ÉúÎ﹦ÄܲÄÁϰå¿éÓ¦Öú½»Á÷ 2012-11-02 08:41:34
smallbird119: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú, 5 2012-11-02 10:25:58
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ºìÖÛÁ÷ÐÇ: ½ð±Ò+1, ר¼Ò¿¼ºË, »¶ÓÀ´µ½ÉúÎ﹦ÄܲÄÁϰå¿éÓ¦Öú½»Á÷ 2012-11-02 08:41:34
smallbird119: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú, 5 2012-11-02 10:25:58
|
What is the molecular weight of PEGDMA? 1st, cytocompatibility of PEG based hydrogel precursors depends on their Mw, irritance of functional groups, and degradation products. PEGDMA is more biocompatible than their PEGDA references because acrylates are more prone to Michale side reactions, causing inflammation effects. But high Mw PEGDA£¨Mw, 10 K) also succeeded in some cell-encapsulation studies, possibly because of the protection effect of large PEG backbones. So higher Mw is always favorable. 2nd, PEGDMA is with much lower reactivity when compared to PEGDA references. (in your case, you should consider the oxygen inhibition during polymerization. Nitrogen protection is recommended. ) 3rd, HEMA has been widely used for contact lenses, but few researchers use it for cell encapsulation. I think the lack of crosslinking density could be the reason. |

2Â¥2012-11-02 03:38:25
smallbird119
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 39 (СѧÉú)
- ½ð±Ò: 3777.9
- É¢½ð: 115
- ºì»¨: 2
- Ìû×Ó: 419
- ÔÚÏß: 165.6Сʱ
- ³æºÅ: 204679
- ×¢²á: 2006-03-02
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ
4Â¥2012-11-02 10:25:39
aircraftvip
ר¼Ò¹ËÎÊ (ÕýʽдÊÖ)
-

ר¼Ò¾Ñé: +40 - BM-EPI: 10
- Ó¦Öú: 232 (´óѧÉú)
- ¹ó±ö: 0.06
- ½ð±Ò: 7345.7
- É¢½ð: 24
- ºì»¨: 28
- Ìû×Ó: 987
- ÔÚÏß: 487.4Сʱ
- ³æºÅ: 1007878
- ×¢²á: 2010-04-28
- ÐÔ±ð: GG
- רҵ: ¸ß·Ö×Ӻϳɻ¯Ñ§
- ¹ÜϽ: ÉúÎï²ÄÁÏ

5Â¥2012-11-02 21:43:15














»Ø¸´´ËÂ¥
